The Asia-Pacific Vaccine Adjuvant Market was worth $84.96 million in 2016 and estimated to be growing at a CAGR of 11.73%, to reach $147.9 million by 2021...
The Asia-Pacific Vaccine Adjuvant Market was worth $84.96 million in 2016 and estimated to be growing at a CAGR of 11.73%, to reach $147.9 million by 2021...